New Delhi–based City Imaging & Clinical Labs (CICL) has unveiled the VITROS 5600 Integrated System  a next-generation diagnostic platform that aims to strengthen lab services in terms of reliability, throughput and quality. 

What makes VITROS 5600 stand out: it merges clinical chemistry and immunoassay testing on a single automated platform, eliminating the need for separate instruments or multiple sample tubes. The system supports more than 160 different assays  covering the vast majority of routine laboratory diagnostics  and can handle up to 900 tests per hour, enabling rapid turnaround of patient reports. 

The platform uses dry-slide technology (waterless chemistry) combined with chemiluminescence detection, which improves result stability, reduces interferences, and enhances sensitivity  especially important for immunoassays and hormone tests.  By processing all tests from a single tube, the system reduces manual intervention, lowers risk of sample mishandling or cross-contamination, and decreases pre-analytic errors, adding to diagnostic reliability. 

According to CICL’s leadership, this upgrade is aligned with their mission to provide “patient-centric diagnostics”  delivering dependable, high-quality, timely results to clinicians and patients alike. 

This move also comes as part of CICL’s broader expansion plan: over the past year, they have grown hospital-laboratory-management (HLM) operations across multiple hospitals, and envisage extending services to many more by 2027.